These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11888251)

  • 1. Toxoplasma gondii: mechanism of the parasitostatic action of 6-thioxanthine.
    Pfefferkorn ER; Bzik DJ; Honsinger CP
    Exp Parasitol; 2001 Dec; 99(4):235-43. PubMed ID: 11888251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxoplasma gondii: characterization of a mutant resistant to 6-thioxanthine.
    Pfefferkorn ER; Borotz SE
    Exp Parasitol; 1994 Nov; 79(3):374-82. PubMed ID: 7957757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mechanism of mycophenolic acid resistance in the protozoan parasite Tritrichomonas foetus.
    Hedstrom L; Cheung KS; Wang CC
    Biochem Pharmacol; 1990 Jan; 39(1):151-60. PubMed ID: 1967525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection based on the expression of antisense hypoxanthine-xanthine-guanine-phosphoribosyltransferase RNA in Toxoplasma gondii.
    Nakaar V; Ngo EO; Joiner KA
    Mol Biochem Parasitol; 2000 Sep; 110(1):43-51. PubMed ID: 10989144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxanthine, guanine, xanthine phosphoribosyltransferase activity in Cryptosporidium parvum.
    Doyle PS; Kanaani J; Wang CC
    Exp Parasitol; 1998 May; 89(1):9-15. PubMed ID: 9603483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxoplasma gondii: the biochemical basis of resistance to emimycin.
    Pfefferkorn ER; Eckel ME; McAdams E
    Exp Parasitol; 1989 Aug; 69(2):129-39. PubMed ID: 2526747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purine metabolism in Toxoplasma gondii.
    Krug EC; Marr JJ; Berens RL
    J Biol Chem; 1989 Jun; 264(18):10601-7. PubMed ID: 2732241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships for the binding of ligands to xanthine or guanine phosphoribosyl-transferase from Toxoplasma gondii.
    Naguib FN; Iltzsch MH; el Kouni MM; Panzica RP; el Kouni MH
    Biochem Pharmacol; 1995 Nov; 50(10):1685-93. PubMed ID: 7503772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-stranded RNA specific to adenosine kinase and hypoxanthine-xanthine-guanine-phosphoribosyltransferase retards growth of Toxoplasma gondii.
    Yu L; Gao YF; Li X; Qiao ZP; Shen JL
    Parasitol Res; 2009 Jan; 104(2):377-83. PubMed ID: 18836745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insertional tagging, cloning, and expression of the Toxoplasma gondii hypoxanthine-xanthine-guanine phosphoribosyltransferase gene. Use as a selectable marker for stable transformation.
    Donald RG; Carter D; Ullman B; Roos DS
    J Biol Chem; 1996 Jun; 271(24):14010-9. PubMed ID: 8662859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mode of action of 2-amino-6-chloro-1-deazapurine.
    Bennett LL; Smithers D; Rose LM; Adamson DJ; Brockman RW
    Biochem Pharmacol; 1984 Jan; 33(2):261-71. PubMed ID: 6142712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INHIBITION OF PRUINE PHOSPHORIBOSYLTRANSFERASES OF EHRLICH ASCITES-TUMOUR CELLS BY 6-MERCAPTOPURINE.
    ATKINSON MR; MURRAY AW
    Biochem J; 1965 Jan; 94(1):64-70. PubMed ID: 14342250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and metabolic effects of 2-azahypoxanthine and 2-azaadenosine.
    Bennett LL; Smithers D; Rose LM; Adamson DJ; Shaddix SC; Thomas HJ
    Biochem Pharmacol; 1985 Apr; 34(8):1293-304. PubMed ID: 2859858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purine salvage in Entamoeba histolytica.
    Lo HS; Wang CC
    J Parasitol; 1985 Oct; 71(5):662-9. PubMed ID: 2865346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purine metabolism in Neisseria meningitidis. 3. Utilization of exogenous hypoxanthine, guanine and xanthine.
    Jyssum S
    Acta Pathol Microbiol Scand B; 1975 Oct; 83(5):397-406. PubMed ID: 809993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structures of the Toxoplasma gondii hypoxanthine-guanine phosphoribosyltransferase-GMP and -IMP complexes: comparison of purine binding interactions with the XMP complex.
    Héroux A; White EL; Ross LJ; Borhani DW
    Biochemistry; 1999 Nov; 38(44):14485-94. PubMed ID: 10545170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of guanine and hypoxanthine phosphoribosyltransferases in Methanococcus voltae.
    Bowen TL; Lin WC; Whitman WB
    J Bacteriol; 1996 May; 178(9):2521-6. PubMed ID: 8626317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered delta ribozymes can simultaneously knock down the expression of the genes encoding uracil phosphoribosyltransferase and hypoxanthine-xanthine-guanine phosphoribosyltransferase in Toxoplasma gondii.
    Sheng J; Al-Anouti F; Ananvoranich S
    Int J Parasitol; 2004 Mar; 34(3):253-63. PubMed ID: 15003487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of inorganic phosphate on hypoxanthine transport in isolated brain microvessels.
    Cardelli P; Fiori A; Santulli MC; Ceci F; Salerno C; Savi MR; Peresempio V; Strom R
    Biochem Int; 1992 Dec; 28(5):823-34. PubMed ID: 1363191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of utilization of hypoxanthine and guanine in cells treated with the carbocyclic analog of adenosine. Phosphates of carbocyclic nucleoside analogs as inhibitors of hypoxanthine (guanine) phosphoribosyltransferase.
    Bennett LL; Brockman RW; Rose LM; Allan PW; Shaddix SC; Shealy YF; Clayton JD
    Mol Pharmacol; 1985 Jun; 27(6):666-75. PubMed ID: 2987661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.